Bicycle Therapeutics director Charles Swanton resigns effective immediately

BICYCLE THERAPEUTICS PLC

On August 18, 2026, Charles Swanton resigned as Class II director, committee member, and Clinical Advisory Board member.
Resignation effective immediately; cited personal reasons, no disagreement with company operations.
Ticker BCYC; resignation disclosed in Form 8-K filed August 20, 2026.

item 5.02

BICYCLE THERAPEUTICS PLC filing history →

Source: SEC EDGAR

accession 0001104659-26-099221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.